Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microbiome of the Eye

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Statistical Evaluation of Smartphone-Based Automated Grading System for Ocular Redness Associated with Dry Eye Disease and Implications for Clinical Trials.

Clinical ophthalmology (Auckland, N.Z.)·2025

Same author

Evolving Dynamics of Relational Coordination: A Study of Progression of Care Huddles in Hospital Observation Services.

Medical care research and review : MCRR·2024

Same author

Advantages of Lissamine Green Vital Staining as an Endpoint in Dry Eye Clinical Trials.

Clinical ophthalmology (Auckland, N.Z.)·2024

Same author

Nurses' Work Concerns and Disenchantment During the COVID-19 Pandemic: Machine Learning Analysis of Web-Based Discussions.

JMIR nursing·2023

Same author

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1).

The ocular surface·2022

Same author

TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China.

International ophthalmology·2022

Search research articles

Related Experiment Video

Updated: Jul 18, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Methodologies for the study of ocular surface disease.

George W Ousler¹, Paulo J Gomes, Donna Welch

¹Harvard Medical School and Schepens Eye Research Institute, Boston, MA 01845, USA.

The Ocular Surface

|November 30, 2006

Summary

Controlled allergen challenge (CAC) and controlled adverse environment (CAE) models improve the reliability of clinical trials for ocular allergic and dry eye diseases. These methods ensure reproducible results by standardizing variables and subject responses.

More Related Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

Related Experiment Videos

Last Updated: Jul 18, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

Area of Science:

Ophthalmology
Clinical Trials
Ocular Surface Disease

Background:

Clinical trials for ocular allergic and dry eye diseases often lack reliability due to uncontrolled variables like environment and patient lifestyle.
Individual fluctuations and compliance issues further complicate the assessment of treatment efficacy.

Purpose of the Study:

To introduce and validate the controlled allergen challenge (CAC) model for allergic conjunctivitis.
To introduce and validate the controlled adverse environment (CAE) model for dry eye disease.
To demonstrate how these models enhance the reproducibility and accuracy of ocular surface disease clinical trials.

Main Methods:

The CAC model elicits allergic conjunctivitis signs and symptoms in a controlled, reproducible manner using strict subject selection and standardized grading.
The CAE model mimics environmental triggers for ocular surface drying in preselected subjects with homogeneous baseline reactions.
Both models utilize quantified grading systems and controlled conditions to establish a reproducible baseline for treatment comparison.

Main Results:

CAC and CAE models provide physiologically accurate and reproducible disease elicitation.
Standardized methods allow for the assessment of statistically and clinically significant differences between therapeutic formulations.
These models enable the significant evaluation and comparison of treatments for highly variable ocular surface conditions.

Conclusions:

The CAC and CAE models offer accurate and reproducible methods for studying ocular allergic and dry eye diseases.
These controlled models address the limitations of traditional clinical trials by minimizing variability.
They provide a reliable foundation for comparing the efficacy of different ocular surface disease treatments.